Home --- The Group --- Licensing and alliances

Licensing and alliances

Thanks to its consolidated wide know how in oncology and its technological platforms discovery, NMS Group has been building strategic alliances and partnerships in order to promote the discovery and development of new innovative treatments for cancer.

In particular, the Group has licensed specific projects at both preclinical and clinical stage and has implemented R&D collaboration.

In these recent years Nerviano Medical Sciences has capitalized its discoveries in international agreements with representative pharmaceutical and biotech companies worldwide among which: